Impacts on Premiums, Enrollment If the ACA Is Modified
Ending the subsidies offered under the Affordable Care Act would sharply increase costs for consumers, according to a study from the RAND Corporation. Furthermore, without the subsidies, more than 11 million Americans will lose their health insurance.
Nanotechnology Can Aid Early Cancer Diagnosis
This novel fluorescent imaging technique uses shortwave IR, which has much better tissue penetration than near-IR currently used in imaging.
Healthy Competition Can Reduce Healthcare Costs
The study, published in JAMA, evaluates the impact of the a decrease in single-physician practices as doctors prefer to join larger healthcare organizations.
The Commonwealth Fund Launches A Healthcare Quality Measurement Tool maintained by The Commonwealth Fund is a free resource for healthcare professionals interested in tracking performance on various measures of healthcare quality.
Nine in 10 Uninsured Don’t Know When Open Enrollment Begins
Congressional candidates may be still be talking about the Affordable Care Act, but a majority of the uninsured are still unaware of main components of the law, according to a poll from the Kaiser Family Foundation.
Fast Track for Taiho Oncology's mCRC Molecule
Taiho Oncology, Inc, announced that the FDA granted Fast Track designation for an oral combination anticancer drug under investigation for the treatment of refractory metastatic colorectal cancer.
In the Literature: New Lead in Treating ALL
The paper, published in Nature, has identified a "switch" that can be inhibited to restrict tumor growth.
CDC's New Directive on PPE for Healthcare Workers Treating Ebola Patients
The CDC has released guidelines with detailed information on the type of personal protective equipment and the procedure for donning and removing, for healthcare workers managing Ebola patients.
Patients Are the “Missing Piece” for ACO Success
Industry experts discussed the big issues facing accountable care organizations (ACO) at the Brookings Institute’s event, The State of Accountable Care: Evidence to Date and Next Steps, held Monday in Washington, DC.
Including Panobinostat Improves PFS in Multiple Myeloma
Including panobinostat in a regimen that included bortezomib and dexamethasone improved median PFS to 11.9 months as compared with 8.08 months in the control arm.
A SNP That Affords Protection From Breast Cancer Identified
The study, published in the journal Nature Communications, identified the single nucleotide polymorphism near the coding region of the estrogen receptor ESR1 among Latina women.
Data Collection, Telehealth, and Importance of Primary Care Physicians Get Attention at ACO Coalition Meeting
Attendees at the ACO and Emerging Healthcare Delivery Coalition meeting held October 16-17, 2014, in Miami, Fla., gained insights to help physicians and accountable care organizations achieve the “Triple Aim” of better population health, greater patient satisfaction, and lower costs. This initiative of The American Journal of Managed Care has now attracted more than 120 members.
ONC Interoperability Roadmap Draft Unveils Guiding Principles
The Office of the National Coordinator for Health Information Technology unveiled a draft for its 10-year plan for healthcare interoperability at a joint meeting on October 15.
New Initiative Seeks to Harness Data to Improve Community Health
A new initiative from the Robert Wood Johnson Foundation will explore how health information and data can be used to improve health in the community.
FDA Allows Testing of Ebola Experimental Drug by Chimerix
Brincidofovir is being developed by the company against several different viruses, including smallpox and Ebola.
CMS Issues Draft Coverage Decision For Prostate Cancer Test by GenomeDX
The Decipher test is intended for use in men who have undergone radical prostatectomy and are at a high risk of disease recurrence.
Myriad’s Prostate Cancer Test Receives Draft Medicare Coverage
Myriad Genetics, Inc., announced today that the Medicare Administrative Contractor (MAC) that has jurisdiction over most molecular diagnostic tests has issued its draft notice on how Medicare will provide reimbursement for Prolaris, a test that Myriad has developed to guide treatment decisions in prostate cancer.
Janssen's Imbruvica Approved by the European Commission
Imbruvica (ibrutinib) is a first-in-class BTK inhibitor with potential for treating blood cancer, indicated for use in MCL and CLL patients.
Roche Joins the Immuno-oncology Front With a PD-L1 inhibitor
While the current approved immuno-oncolgy drugs have been approved for melanoma, Roche has also been evaluating their new molecule in triple-negative breast cancer. The results will be presented at the San Antonio Breast Cancer Symposium.
More Providers, Insurers Showing Appetite for Narrow Networks
Providers and insurers across the country are partnering to launch narrow-network plans even as controversy continues over whether these plans offer adequate provider access for consumers.
Malpractice “Immunity” Does Not Prevent Wasteful Spending
Legal reforms that enact stronger protections against malpractice claims do not necessarily reduce defensive care, according to a new study by the RAND Corporation published in the New England Journal of Medicine.
Massachusetts Caught in Scheme to Over-Charge Medicaid by $106 Million
Massachusetts health officials over-billed Medicaid for almost $106 million by filing claims from as far back as 1988 as current expenses, according to an HHS inspector general's report.
Reducing Hospital Readmissions May Prove Tougher than CMS Expects, AJMC Study Finds
The Centers for Medicare and Medicaid Services wants hospitals to find ways to keep patients from returning to the hospital, and the agency has created rewards and punishments in pursuit of this goal. A study in The American Journal of Managed Care is just one of a pair of recent clinical trials that finds readmissions may be beyond some hospitals’ control, and policymakers might need to rethink their approach.
AMA Calls for More Meaningful Use Flexibility in Letter to CMS, ONC
The strict rules of the Meaningful Use (MU) program are preventing physicians from participating, according to the American Medical Association, which is calling for more flexibility and some relief from penalties.